Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
Adelina Orellana(Universitat Internacional de Catalunya), Agustı́n Ruiz(The University of Texas at San Antonio Health Science Center), Leire Narvaiza(Universitat Internacional de Catalunya), Marta Marquié(Biomedical Research Networking Center on Neurodegenerative Diseases), Alberto Lleó(Hospital de Sant Pau), Laura Montrreal(Universitat Internacional de Catalunya), Itziar de Rojas(Instituto de Salud Carlos III), Maitée Rosende‐Roca(Universitat Internacional de Catalunya), Ester Esteban‐De Antonio(Universitat Internacional de Catalunya), Urszula Bojaryn(Universitat Internacional de Catalunya), Amanda Cano(Instituto de Salud Carlos III), Merçé Boada(Instituto de Salud Carlos III), Montserrat Alegret(Instituto de Salud Carlos III), Vanesa Pytel(Universitat Internacional de Catalunya), Sergi Valero(Universitat Internacional de Catalunya), Juan Pablo Tartari(Universitat Internacional de Catalunya), Pablo García‐González(Instituto de Salud Carlos III), Daniel Alcolea(Hospital de Sant Pau), Isabel Hernández(Universitat Internacional de Catalunya), Liliana Vargas(Universitat Internacional de Catalunya), Lluís Tárraga(Universitat Internacional de Catalunya), Emilio Alarcón‐Martín(Universitat Internacional de Catalunya)
Cited by 75
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Validating novel tau positron emission tomography tracer <scp>[F‐18]‐AV‐1451 (T807)</scp> on postmortem brain tissue
|Annals of Neurology|2015|626